What volume of 40 mg/5 mL famotidine suspension should be given per dose to a 69‑lb (≈31 kg) child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Famotidine Dosing Calculation for a 69-lb Child

For a 69-lb (31 kg) child using a 40 mg/5 mL famotidine suspension, give 3.9 mL per dose (approximately 4 mL for practical administration).

Weight Conversion and Dose Calculation

  • A 69-lb child weighs approximately 31.3 kg 1
  • Standard pediatric famotidine dosing is 0.5 mg/kg per dose for children, based on pharmacokinetic studies showing this achieves therapeutic gastric acid suppression 2, 3

Step-by-Step Calculation

Dose in mg:

  • 31 kg × 0.5 mg/kg = 15.5 mg per dose 3

Volume calculation with 40 mg/5 mL concentration:

  • Set up proportion: 40 mg/5 mL = 15.5 mg/X mL
  • X = (15.5 mg × 5 mL) ÷ 40 mg
  • X = 3.875 mL per dose 2

Practical administration: Round to 3.9 mL or 4 mL per dose 4

Dosing Frequency

  • Administer every 12 hours (twice daily) for children over 3 months of age 3
  • This weight-based regimen (0.5 mg/kg/dose twice daily) maintains gastric pH above 4.0 for approximately 9 hours per dose in pediatric patients 5

Important Clinical Considerations

  • Do not exceed adult doses: Maximum single dose should not exceed 40 mg, even if weight-based calculation suggests higher 6
  • For this 31 kg child, the calculated 15.5 mg dose is well below the 40 mg adult maximum 2
  • Bioavailability in children 11-15 years is similar to adults (approximately 40-45%), supporting weight-based dosing 2, 7

Common Pitfalls to Avoid

  • Concentration confusion: Ensure you're using 40 mg/5 mL, not confusing with other concentrations 1
  • Renal function: If the child has renal impairment (creatinine clearance <60 mL/min), reduce dose by 50% or more depending on severity 2, 8
  • Tachyphylaxis: Prolonged IV use leads to decreased duration of efficacy, though this is less documented with oral therapy 5

References

Guideline

Medication Dosing Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacokinetics of famotidine in infants.

Clinical pharmacokinetics, 2005

Guideline

Ondansetron Dosing Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical pharmacokinetics of famotidine.

Clinical pharmacokinetics, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.